Riamilovir 新

参考资料仅供科学研究，不可用于个人用途。

货号：BCP41717CAS号：123606-06-4纯度：98%

在线咨询

购买咨询

全国免运费！免费咨询：400-099-8200 或手机联系：13472751340

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS号	123606-06-4	货号	BCP41717
中文名	Riamilovir
英文名	Riamilovir
中文别名
英文别名	Triazavirin; TZV;
SMILES	CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-]
化学名称
分子式	C5H4N6O3S	分子量	228.19
纯度	98%	配送	惯例下常温包邮
产品描述	Riamilovir, also known as Triazavirin, is an antiviral drug candidate. Tiazavirin is a broad-spectrum antiviral drug developed in Russia. It has a novel triazolotriazine core, which represents a new structural class of non-nucleoside antiviral drugs. It was originally developed as a potential treatment for pandemic influenza strains such as H5N1, and most of the testing that has been done has focused on its anti-influenza activity. However triazavirin has also been found to have antiviral activity against a number of other viruses including Tick-borne encephalitis virus, and Forest-Spring Encephalitis virus, and is also being investigated for potential application against Lassa fever and Ebola virus disease. In February 2020, testing of triazavirin was started against SARS-CoV-2.